A drug with the SMILES CCOc1ccc(N(CC(=O)Nc2ccccc2C)S(=O)(=O)c2c(C)[nH]c(=O)[nH]c2=O)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 3.242%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCOc1ccc(N(CC(=O)Nc2ccccc2C)S(=O)(=O)c2c(C)[nH]c(=O)[nH]c2=O)cc1
CCOc1ccc(N(CC(=O)Nc2ccccc2C)S(=O)(=O)c2c(C)[nH]c(=O)[nH]c2=O)cc1
2-[4-ethoxy-N-[(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)sulfonyl]anilino]-N-(2-methylphenyl)acetamide